News

The company will use the Medidata Solutions (MDSO) platform in phase II clinical trial to test a vaccine. The Medidata’s integrated solutions are expected to drive trial efficiencies

Under the agreement, Bayer will be responsible for any subsequent clinical development and commercialization. For the development, Evotec will receive €12m as an upfront payment and may also

As part of the renewed agreement, Elite will carry on with manufacturing and packaging for TPN’s methadone hydrochloride, 10 mg tablets through 31 December 2014. Ascend Laboratories and

Vancomycin is designed to help reduce medication errors and features the company’s PreventIV Measures packaging and labeling. The injection is used to treat infections caused by susceptible strains

Humira, which works by inhibiting tumour necrosis factor-alpha (TNF-alpha), was previously approved for the treatment of moderate to severe Crohn’s disease. Abbott Global Pharmaceutical Research and Development senior

The partnership, a part of its Prime Site program, is designed to increase access to clinical trials for both patients and investigators, quickening the collection of data about

According to the merger agreement, Par’s stockholders are eligible to earn $50.00 in cash, without interest, less any applicable withholding taxes, for each share of Par common stock

The FDA has also approved the company’s ANDA for Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5mg and 300/12.5 mg, the generic version of Sanofi’s Avalide. The company announced the

Bevacizumab is a biologic antibody designed to interfere with the tumor blood supply by directly binding to a protein called VEGF and helps curing recurrent glioblastoma while TH-302